What is the appropriate daily oral dose of cyanocobalamin (vitamin B12) for supplementation in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Daily Oral Vitamin B12 Supplementation Dose

For routine daily oral vitamin B12 supplementation in adults, use 1000 mcg (1 mg) per day of cyanocobalamin. This dose is supported by FDA labeling 1 and is the most commonly validated dose across clinical studies for both prevention and treatment of deficiency.

Dosing Framework

Standard Supplementation (Healthy Adults)

  • Maintenance/Prevention: The ESPEN guideline notes that the adequate intake (AI) for healthy adults is 4 mcg/day, with 5 mcg/day in pregnancy and 4.5 mcg/day in lactation 2
  • Practical supplementation dose: 1000 mcg daily orally 1
    • This far exceeds physiological needs but accounts for the limited bioavailability of oral B12
    • Active absorption saturates at approximately 1.2 mcg per dose, with only ~1% passive absorption at higher doses 3

Treatment of Deficiency

The dose depends on the clinical context:

For mild deficiency without neurological symptoms:

  • 500-1000 mcg daily is effective 4, 5
  • Studies demonstrate that 500 mcg/day reverses biochemical markers of deficiency 5
  • The dose-finding trial showed that 647-1032 mcg daily achieved 80-90% of maximal reduction in methylmalonic acid 4

For food-cobalamin malabsorption:

  • 250-1000 mcg daily 6, 7
  • Lower doses (250 mcg/day) can correct deficiency within one week 7
  • However, higher initial doses (1000 mcg daily or every other day) provide greater dose-effect 7

For pernicious anemia:

  • 1000 mcg daily orally is effective 6, 8
  • Recent prospective data confirms that 1000 mcg/day cyanocobalamin successfully treats PA, with 88.5% of patients no longer deficient after 1 month 8
  • This challenges the traditional dogma that PA requires intramuscular therapy

Key Clinical Considerations

Why Such High Doses?

The recommended supplementation dose (1000 mcg) is more than 200 times the RDA of ~3 mcg/day 4. This is necessary because:

  • Active absorption via intrinsic factor saturates at ~1.2 mcg per dose 3
  • Passive absorption accounts for only ~1% of the dose at higher levels 3
  • To achieve adequate absorption, especially in malabsorption states, pharmacologic doses are required

Oral vs. Intramuscular

While the bariatric surgery guidelines 9 recommend intramuscular therapy for established B12 deficiency (1 mg IM three times weekly for 2 weeks, then every 2-3 months for maintenance), oral therapy at 1000 mcg daily is equally effective for most patients, including those with pernicious anemia 10, 8. The IM route is reserved for:

  • Neurological involvement (requires alternate-day IM dosing until improvement) 9
  • Documented failure of oral therapy
  • Severe malabsorption or intolerance to oral route

Dose Comparison: 1000 mcg vs. 2000 mcg

A recent 2026 trial in diabetic neuropathy patients found no additional neuropathic benefit from 2000 mcg compared to 1000 mcg daily, though the higher dose did produce greater serum B12 elevation 11. This supports 1000 mcg as the optimal dose for most clinical scenarios.

Common Pitfalls

  1. Don't start folic acid before excluding B12 deficiency - This can mask B12 deficiency and precipitate subacute combined degeneration of the spinal cord 9

  2. Don't assume oral therapy won't work in pernicious anemia - Modern evidence shows 1000 mcg daily oral cyanocobalamin is effective even in PA 8

  3. Don't use inadequate doses - Doses below 500 mcg daily may be insufficient to correct deficiency 4, 5

  4. Monitor response - Check B12 levels and functional markers (methylmalonic acid, homocysteine) at 3 months to confirm adequacy 2

References

Guideline

espen micronutrient guideline.

Clinical Nutrition, 2022

Research

Oral cobalamin (vitamin B(12)) treatment. An update.

International journal of laboratory hematology, 2009

Research

Oral vitamin B12 supplementation in pernicious anemia: a prospective cohort study.

The American journal of clinical nutrition, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.